DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Sulbactam
Sulbactam
Medical Review(S) Clinical Review
“Ceftriaxone– Sulbactam–EDTA” and Various Antibiotics Against Gram
Antimicrobial Susceptibility Among Colistin, Sulbactam, And
Activity of Imipenem, Meropenem, Cefepime, and Sulbactam in Combination with the Β-Lactamase Inhibitor LN-1-255 Against Acinetobacter Spp
In Vitro Susceptibilities of Escherichia Coli and Klebsiella Spp. To
Antimicrobial Stewardship Guidance
Below Are the CLSI Breakpoints for Selected Bacteria. Please Use Your Clinical Judgement When Assessing Breakpoints
UNASYN® (Ampicillin Sodium/Sulbactam Sodium)
Consideration of Antibacterial Medicines As Part Of
Ampicillin/Sulbactam Vs. Cefoxitin for the Treatment of Pelvic Inflammatory Disease
Use of Ceftaroline Fosamil in Osteomyelitis: CAPTURE Study Experience Leonard B
A Multicentre Clinical Study on the Injection of Ceftriaxone/Sulbactam
Drug Specific Supplement for MTS™ Ampicillin-Sulbactam
Colistin Plus Sulbactam Or Fosfomycin Against Carbapenem-Resistant Acinetobacter Baumannii: Improved Efficacy Or Decreased Risk of Nephrotoxicity?
National Treatment Guidelines for Antimicrobial Use in Infectious Diseases
Ceftriaxone and Sulbactam Injection
Surgical Antibiotic Prophylaxis
Antibacterial Prodrugs to Overcome Bacterial Resistance
Top View
In Vitro Activity of Colistin Or Sulbactam In
Safety and Efficacy of a Novel Drug Elores
Table V: Recommended Antimicrobial Prophylaxis for Urologic Procedures
Idweek15 Ceftaroline BSI-SSSI 1543.Pdf
June 2016 Version
Evaluation of the Synergistic Antibacterial Effects of Fosfomycin in Combination with Selected Antibiotics Against Carbapenem–Resistant Acinetobacter Baumannii
Penicillin Allergy Cross-‐Reactivity • Roughly 10% of the Population
Handbook of Outpatient Parenteral Antimicrobial Therapy (OPAT)
The Antibacterial Activity of Sulbactam and the Novel Β-Lactamase
Disks for Antibiotic Susceptibility Testing 50 Disks Cartridge Study of Susceptibility to Antimicrobial Agents
Ceftaroline Efficacy and Safety in Treatment of Complicated Skin And
A New Fixed Dose Combination of Ceftriaxone + Sulbactam +
Ampicillin/Sulbactam
Comparison of Efficacy of Cefoperazone/Sulbactam and Imipenem/Cilastatin for Treatment of Acinetobacter Bacteremia
Fosfomycin: Pharmacological, Clinical and Future Perspectives
Peritoneal Dialysis Antimicrobial Dosing Recommendations
A Comparative Study of Ceftriaxone and Ceftriaxone + Sulbactam in the Prevention of Post-Operative Infections in a Surgical Unit
Ceftriaxone / Sulbactam for Treatment of Bacterial Infections
Comparative Efficacies of Amoxicillin-Clavulanic Acid
Surgical Prophylaxis Guideline Updates
UNASYN (Sulbactam Sodium/Ampicillin Sodium) for Intravenous Or Intramuscular Use
Therapy Options for Acinetobacter Infections Viewed from the East
Susceptibility Testing Β-Lactamase Inhibitor Combinations
Antimicrobial Activity of Ceftaroline Tested Against 10,956 Organisms
INVANZ® (Ertapenem Sodium)
Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery
Antimicrobial Activity of Ceftaroline and Comparator Agents Tested Against Organisms Helio S
2017 State Antibiogram & Implications for Antibiotic
Double Anaerobic Coverage: What Is the Role in Clinical Practice?
SCIP—Inpatient Antibiotic Recommendations
Spectrum and Potency of Ceftaroline Against Leading Pathogens Causing Community-Acquired Respiratory Tract and Skin and Soft Tissue Infections in Latin America, 2010
IV to PO Antibiotic Step-Down Guidelines
Pharmacokinetics and Tolerability of Intravenous Sulbactam
EAU Urological Infections Antibacterial Agents
Open-Label Randomized Trial of Early Clinical Outcomes of Ceftaroline
Sulbactam Combined with the Novel Β-Lactamase Inhibitor ETX2514 For
Original Article Which Antibiotoc Is Better to Select Empirically for Lower Urinary Tract Infections in Pregnant Women?
A Comparative Study of Sulbactomax Versus Ceftriaxone and Betalactamase Inhibitor and Their Effect on Mutant Prevention in ESBL Producing Organisms
Guidelines for Treatment of Skin and Soft Tissue Infections These Guidelines Are Not Intended to Replace Clinical Judgment
Surgical Antibiotic Prophylaxis
Ampicillin/Sulbactam Current Status in Severe Bacterial Infections
Resistance to Sulbactam-Durlobactam in Clinical Isolates of Acinetobacter Baumannii Is Rare and Maps to PBP3 Samir H
Three-Day Ertapenem Versus Three-Day Ampicillin